IRVINE, Calif.—Edwards Lifesciences Corp., which makes heart valves and other cardiovascular products, raised its full-year profit outlook Tuesday after it reported better-than-expected second-quarter financial results.
The company boosted full-year guidance by 5 cents per share to between $2.50 and $2.58 per share, while tightening its revenue outlook by $25 million to between $1.24 billion and $1.28 billion.
Analysts polled by Thomson Financial expect profit of $2.50 per share on revenue of $1.23 billion.
In the third quarter, the company expects profit between 53 cents and 57 cents per share, while analysts forecast 56 cents per share.
Shares of Edwards Lifesciences rose 10 cents to close at $65.25.
© Copyright 2008 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
